Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > List goes on and on

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Nov 20, 2023 3:55pm

173 Views

Post# 35745130

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:List goes on and on

Does the date really matter without investor context? Something like this would be useful: "we raised $1.5M and should cover us operationally through Q12024, which is our best estimate for FDA direction on BTD, inclusive of the pre-BTD process currently under way". IMO.

Pandora wrote:
m8magic wrote: they said the week of nov 20

exact words:

"The Offering is scheduled to close on or about the week of November 20, 2023 and is subject to the receipt of all necessary approvals, including the approval of the TSXV ("Closing Date")."